Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $40.51
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 20, 26 | Citigroup | downgrade | Buy | Neutral |
| Apr 8, 26 | Citigroup | upgrade | Neutral | Buy |
| Mar 14, 25 | Barclays | upgrade | Equal Weight | Overweight |
| Oct 4, 23 | Goldman Sachs | upgrade | Neutral | Buy |
| Mar 5, 20 | UBS | upgrade | Sell | Neutral |
| Mar 3, 20 | B of A Securities | maintain | Buy | Buy |
| Jan 21, 20 | Citigroup | upgrade | Neutral | Buy |
| Sep 24, 18 | Barclays | upgrade | Equal Weight | Overweight |
| Feb 12, 18 | Barclays | downgrade | Overweight | Equal Weight |
1255 daily bars · split adjusted
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
RELX PLC (RELX) Q3 2026 Sales/Trading Call Transcript
Relx NYSE: RELX reported 7% underlying revenue growth for the first nine months of the year, with CFO Nick Luff saying the company continued to see positive momentum across its portfolio as it shifts its business mix toward higher-growth analytics and decision tools.
Despite consistent EPS compounding and reliable growth, RELX's valuation has derated significantly, trading near 50% of its all-time high P/E. Perceived disruption to the legal and STM segments has turned into opportunities, and consistent growth has been maintained. The high-margin Risk segment dominates digital identity screening and fraud prevention, protected by a self-compounding, 13-petabyte data moat.
TTM vs. 5-year historical average (annual ratios)
| Metric | RELX | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 24.1x | 30.7x · sector 18.4x | Elevated |
| Forward P/E (FY26E) | 28.7x | EPS est. 1.41 | Elevated |
| Price / Book | 43.9x | 17.2x | Elevated |
| Price / Sales | 5.4x | 6.2x | In line |
| EV / EBITDA | 15.8x | 18.5x | In line |
| Return on equity | 125.5% | — | Top tier |
| Gross margin | 62.7% | 64.5% | In line |
| Debt / Equity | 7.19 | 2.11 | Levered |
| Piotroski / Altman Z | 6/9 | Z 3.26 | Safe zone |
Discounted cash flow model
Daily · Wilder smoothing
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 23, 2026 | 0.89 | 0.91 | Beat 2.2% | $6.49B |
| Feb 12, 2026 | 0.85 | 0.81 | Miss -5.2% | $6.62B |
| Jul 24, 2025 | 0.56 | 0.86 | Beat 52.8% | $6.42B |
| Feb 13, 2025 | 0.80 | 0.78 | Miss -1.8% | $6.19B |
| Oct 24, 2024 | — | 0.66 | — | $5.87B |
| Jul 25, 2024 | 0.77 | 0.77 | Beat 0.0% | $5.98B |
| 6-K | Sep 8, 2026 | 2026-09-08 11:49:41 | View |
| 6-K | Sep 1, 2026 | 2026-09-01 11:09:29 | View |
| 6-K | Aug 27, 2026 | 2026-08-27 06:23:29 | View |
| 6-K | Aug 6, 2026 | 2026-08-06 08:13:39 | View |
| 6-K | Aug 3, 2026 | 2026-08-03 13:44:16 | View |
| 6-K | Jul 23, 2026 | 2026-07-23 09:24:44 | View |
Proxy statement (DEF 14A) disclosures
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 79.37 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 92.78 | Oscillator | Sell |
| Williams %R (14) | -5.82 | Oscillator | Sell |
| MACD (12, 26, 9) | 1.54 (Hist 0.52) | Oscillator | Strong Buy |
| Average Directional Index (14) | 33.43 (+DI 42.3 / -DI 12.3) | Trend | Strong Buy |
| EMA 20 | 37.28 | MA | Strong Buy |
| SMA 20 | 36.33 | MA | Strong Buy |
| EMA 50 | 35.83 | MA | Strong Buy |
| SMA 50 | 35.41 | MA | Strong Buy |
| SMA 200 | 34.57 | MA | Strong Buy |